Federica Barbieri

12PUBLICATIONS
40CO-AUTHORS
Molecular targetsGene and molecular therapyHaematological tumoursRadiation therapyNanoscale characterisation
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|May 13, 2026
Microglia Reprogramming in Glioblastoma: Stem Cell-Derived Factors as Emerging Immunomodulators.

|Jan 20, 2026
Correction: Chronic administration of Metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Nov 23, 2025
Chronic administration of metformin exerts cytostatic and cytotoxic effects via the PP2A-GSK3β-MCL-1 pathway by inhibiting the tmCLIC1 membrane protein in glioblastoma-initiating cells.

Francesca Cianci, Ivan Verduci, Riccardo Cazzoli

|Aug 19, 2024
Human glioblastoma-derived cell membrane nanovesicles: a novel, cell-specific strategy for boron neutron capture therapy of brain tumors.

Alice Balboni, Giorgia Ailuno, Sara Baldassari

|Feb 24, 2024
Development of Biotinylated Liposomes Encapsulating Metformin for Therapeutic Targeting of Inflammation-Based Diseases.

Giorgia Ailuno, Sara Baldassari, Alice Balboni

|Feb 25, 2023
Antitumor Potential of Antiepileptic Drugs in Human Glioblastoma: Pharmacological Targets and Clinical Benefits.

Manuela Stella, Giammarco Baiardi, Stefano Pasquariello

Pageof 2

Frequent Collaborators

9 joint publications

Tullio Florio

4 joint publications

Giorgia Ailuno

3 joint publications

Michele Mazzanti

2 joint publications

Guido Rey